Gut bacteria study in liver cirrhosis patients
Part of Digestive system clinical trials.
This study looks at the bacteria naturally living in your gut (the microbiome) to better understand liver cirrhosis. It does not test a new drug or treatment, only collects information and samples.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older.
- You have been diagnosed with liver cirrhosis.
- You understand the study and agree to join by signing a consent form.
- You have not taken antibiotics in the last 2 weeks and will not take them during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at infections in people with cirrhosis caused by hepatitis B or C. It aims to find which germs cause these infections, so doctors can choose better treatments.
This study looks at the gut microbiome (the helpful bacteria in your gut) and muscle loss (sarcopenia) in people with liver cirrhosis. It may help researchers understand what changes in the gut and body can go along with getting weaker, so better treatments can be developed.
This trial studies whether transferring healthy gut bacteria (from a donor sample) can improve outcomes for people with liver cirrhosis who have worsening complications. It may help by changing the gut microbiome, which can influence inflammation and liver health.
This trial tests whether using remote monitoring (checking your health from home) can help manage liver cirrhosis. It aims to make care easier and catch problems early without extra hospital visits.
This study compares patients with advanced liver scarring (cirrhosis) to healthy controls to learn more about the condition. It may help researchers better understand and manage liver disease.
This study looks at how lactate-related changes in gut bacteria might affect the progression of liver cirrhosis. It includes both healthy people and cirrhosis patients to see how these factors relate.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.